Vir Biotechnology VIR Ratios (2018-2026)

NASDAQ VIR
$11.60 +0.15 (+1.31%)
As of: Sep 4, 2026 · 1:33 PM EDT
Reported Financials

Vir Biotechnology Quarterly Ratios

Periods 32 quarters
Latest Jun 2026

Vir Biotechnology reported a gross margin of 100.00% and a net margin of 33.51% for the quarter ended Jun 2026. These financial ratios cover 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
92.44%93.00%92.69%31.28%94.06%87.86%96.97%99.42%98.56%95.25%99.90%98.31%97.90%94.47%100.00%99.09%100.00%
EBT Margin
106.90%67.17%74.80%-575.26%58.13%-306.90%-227.44%-5,204.71%-6,313.98%-719.35%-115.30%-4,549.27%-8,972.27%-845.93%-3,989.08%-9,125.86%-67,905.42%-67.21%-432,844.83%33.59%
EBIT Margin
-51.52%70.35%82.26%-554.34%52.05%-304.60%-227.73%-5,667.26%-7,075.86%-828.12%-142.05%-5,158.70%-9,718.66%-946.74%-4,602.47%-9,754.28%-72,267.92%-74.79%-456,172.41%30.75%
EBITDA Margin
-51.52%70.35%82.26%-554.34%52.05%-304.60%-227.73%-5,667.26%-7,075.86%-828.12%-142.05%-5,158.70%-9,718.66%-946.74%-4,602.47%-9,754.28%-72,267.92%-74.79%-456,172.41%30.75%
Operating Margin
-51.52%70.35%82.26%-554.34%52.05%-304.60%-227.73%-5,667.26%-7,075.86%-828.12%-142.05%-5,158.70%-9,718.66%-946.74%-4,602.47%-9,754.28%-72,267.92%-74.79%-456,172.41%30.75%
Net Margin
106.57%64.63%42.08%-188.27%46.81%-205.63%-223.80%-5,129.71%-6,192.23%-690.85%-115.79%-4,500.10%-8,979.71%-845.23%-3,989.61%-9,139.87%-67,975.42%-66.99%-433,431.03%33.51%
FCF Margin
-107.92%-0.66%43.35%2,312.48%26.41%45.64%-210.70%-10,500.50%-6,045.59%-652.06%-197.36%-2,553.27%-7,321.34%-724.34%-2,630.11%-10,111.78%-69,952.92%-40.93%-457,848.28%51.60%
Efficiency
Assets AverageAssets Avg.
1,133.90M1,582.24M2,420.70M2,753.06M2,657.48M2,749.03M2,734.01M2,454.91M2,144.38M1,981.98M1,856.51M1,731.76M1,583.96M1,448.58M1,353.27M1,250.13M1,105.99M1,011.14M1,014.20M1,120.20M
Invested CapitalInvested Cap.
944.77M1,431.85M2,001.01M1,590.24M1,166.44M1,061.32M947.47M796.10M765.28M
Asset Utilization RatioAsset Util.
0.250.690.960.800.930.620.190.200.060.040.040.050.050.050.020.020.020.070.060.27
Leverage & Solvency
Debt Ratio
0.060.010.01
Valuation
Price to EarningsP/E
51.5610.466.56-44.1514.63-33.19-22.12-16.91-7.71-11.69-21.08-8.79-4.79-9.61-7.40-6.31-4.87-19.59-11.4921.53
Price to SalesP/S
54.956.762.7683.126.8568.2549.50867.18477.5580.7724.41395.33430.2281.24295.07576.600.00M13.130.05M7.22
Price to BookP/B
6.503.841.701.731.191.621.581.820.750.850.890.850.830.870.860.741.001.101.781.75
Enterprise Value
4,923.47M4,926.73M2,191.95M1,217.97M241.09M1,002.07M885.13M1,458.77M-425.48M-156.66M230.26M68.95M114.97M104.28M103.71M101.24M295.99M380.10M974.22M1,195.41M
EV to EBIT
-92.238.622.16-5.411.24-6.66-6.17-6.782.281.13-2.88-0.43-0.50-0.89-0.74-0.85-1.71-7.93-7.3616.27
EV to EBITDA
-92.238.622.16-5.411.24-6.66-6.17-6.782.281.13-2.88-0.43-0.50-0.89-0.74-0.85-1.71-7.93-7.3616.27
Market Capitalization
5,693.55M5,491.73M3,404.13M3,377.27M2,564.77M3,372.22M3,116.57M3,292.67M1,260.25M1,355.90M1,376.10M1,215.65M1,023.93M1,005.28M894.65M699.99M793.82M841.03M1,444.66M1,724.00M
Price to FCFP/FCF
-50.92-0.00M6.373.5925.93149.53-23.49-8.26-7.90-12.39-12.37-15.48-5.88-11.22-11.22-5.70-4.73-32.07-10.8813.98
EV to FCF
-44.03-917.114.101.302.4444.43-6.67-3.662.671.43-2.07-0.88-0.66-1.16-1.30-0.82-1.76-14.49-7.349.70
EV to CFO
-46.53640.253.981.272.0428.53-7.04-3.752.731.45-2.10-0.89-0.67-1.19-1.33-0.84-1.77-14.69-7.369.69
Return Ratios
Return on Sales [ROS]ROS
-51.52%70.35%82.26%-554.34%52.05%-304.60%-227.73%-5,667.26%-7,075.86%-828.12%-142.05%-5,158.70%-9,718.66%-946.74%-4,602.47%-9,754.28%-72,267.92%-74.79%-456,172.41%30.75%
Return on Capital Employed [ROCE]ROCE
-28.82%33.90%92.72%57.44%66.20%37.22%-14.41%-14.09%-35.15%-37.88%-35.24%-34.52%-41.52%-44.18%-53.18%-52.96%-53.22%-52.20%-50.19%-27.33%
Return on Invested Capital [ROIC]ROIC
-30.53%34.04%68.81%-57.91%-60.41%-62.96%-61.43%
Return on Assets [ROA]ROA
-10.01%33.41%50.24%39.15%43.00%18.76%-5.26%-10.67%-28.01%-31.04%-29.06%-27.89%-33.67%-36.03%-42.69%-44.01%-45.18%-43.32%-43.65%-22.47%